SLU-PP-332

Exercise-mimetic research compound targeting oxidative metabolism

June 27, 2026 Read more

Sermorelin

Classic GHRH analog that prompts the pituitary’s own GH release

June 27, 2026 Read more

Survodutide

Dual glucagon/GLP-1 agonist studied for weight and liver outcomes

June 27, 2026 Read more

Semaglutide

The benchmark GLP-1 agonist behind a generation of metabolic research

June 27, 2026 Read more

Retatrutide

Triple-hormone agonist drawing intense metabolic-research interest

June 27, 2026 Read more